SUMMARY Two years after an orthotopic cardiac transplant a 28 year old man was found to have clinically significant stenosis of the right coronary artery at routine coronary angiography. This lesion was accompanied by a perfusion defect on exercise thallium scintigraphy.
Elizabeth Hospitals, Birmingham and *British Heart Foundation Heart Transplant Resea)ch Unit, Papworth Hospital, Cambridge SUMMARY Two years after an orthotopic cardiac transplant a 28 year old man was found to have clinically significant stenosis of the right coronary artery at routine coronary angiography. This lesion was accompanied by a perfusion defect on exercise thallium scintigraphy.
Percutaneous transluminal coronary angioplasty of the lesion improved the angiographic appearance of the stenosis and reduced the exercise thallium perfusion defect.
The development of coronary artery disease in the transplanted heart is a cause for concern as it is usually asymptomatic and may progress rapidly,' leading to silent myocardial infarction, cardiac failure, or sudden death.2 Retransplantation has been performed in cases in which coronary atherosclerosis had progressed to diffuse, extensive involvement of epicardial vessels.'3 Early detection of coronary disease is therefore important and most centres practise annual angiography of the coronary vessels, usually after the first two years. Because the transplanted heart is denervated, anginal symptoms are absent even when there is severe disease. The most useful approach to management of early discrete lesions is uncertain.
We report a case in which a significant discrete stenosis of the right coronary artery was discovered two years after transplantation; this was (fig la) . Exercise thallium scintigraphy showed a large defect in the lateral segment with moderate reperfusion in the resting images at four hours after exercise (fig 2a) .
In view of these abnormalities, percutaneous transluminal coronary angioplasty of the right coronary artery was undertaken in February 1987. A femoral approach was used with the standard technique of dilatation with a steerable 3 0 mm balloon catheter and a Judkins' guiding catheter. There was no residual angiographic stenosis or complications after dilatation of the lesion (fig lb) . Repeat exercise thallium scintigraphy at six weeks after angioplasty showed a smaller lateral perfusion defect than demonstrated before, but there was no evidence of reperfusion at four hours after exercise (fig 2b) . The Gammage, Shiu, English group.bmj.com on April 19, 2017 -Published by http://heart.bmj.com/ Downloaded from patient remains well and continues to have a good exercise tolerance. Repeat coronary angiography at six months after angioplasty showed a patent right coronary artery with good remodelling and only minor residual stenosis.
Discussion
The aetiology of accelerated coronary occlusive disease in some transplanted hearts is imperfectly understood. It is likely that rejection is a feature, at least as an initiating factor, and both cytotoxic B-cell antibodies and hypercholesterolaemia have been implicated in the pathogenesis.4 Our own experience indicates that there is angiographic evidence of disease in 25% of patients five years after transplantation, whereas others have reported an incidence of 40% at five years.1 Whatever the true figure, coronary artery disease is undoubtedly the most important determinant of survival in the medium and long term after transplantation and if it is severe retransplantation may be required.
There are two reports of angioplasty in transplanted hearts in the United States.56 In both there was multivessel rather than single vessel disease. Our patient had an isolated lesion and, as the donor was a 43 year old man, it is possible that this was present in the donor organ at the time of transplantation. This cannot be disproved because the first angiogram was performed at two years. Initially it was our practice to perform angiography once a year from the first year onwards, but we no longer do this because the incidence ofdisease at one year was so low. Nevertheless, the lesion may have developed between transplantation and the angiogram at two years as, although accelerated coronary occlusive disease is often diffuse, we have found the appearance of segmental lesions after previously normal angiograms within this period.
The role of myocardial perfusion imaging with thallium-201 in the transplanted heart is less well defined than its role in "native" coronary artery disease.7 The single reported case presenting scintigraphic data6 demonstrated an improvement of regional perfusion in the area of a previous perfusion defect after angioplasty ofthe stenosed vessel supplying the region, but other studies of thallium-201 imaging in the transplanted heart with diffuse small vessel disease have demonstrated a poor sensitivity in these circumstances. ' Angioplasty has now been shown to be technically possible in the transplanted heart with single or multiple vessel disease; the long term results in terms of patient and graft survival or vessel patency remain to be assessed.
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